2024 Journal Article Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineeringAlharbi, Mona, Lai, Andrew, Godbole, Nihar, Guanzon, Dominic, Nair, Soumyalekshmi, Zuñiga, Felipe, Quinn, Alexander, Yang, Mengliu, Wu, Sherry Y. and Salomon, Carlos (2024). Enhancing precision targeting of ovarian cancer tumor cells in vivo through extracellular vesicle engineering. International Journal of Cancer, 155 (8), 1510-1523. doi: 10.1002/ijc.35055 |
2024 Journal Article Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growthWilkinson, Andrew N., Chen, Rui, Coleborn, Elaina, Neilson, Trent, Le, Khang, Bhavsar, Chintan, Wang, Yue, Atluri, Sharat, Irgam, Gowri, Wong, Kiefer, Yang, Da, Steptoe, Raymond and Wu, Sherry Y. (2024). Let-7i enhances anti-tumour immunity and suppresses ovarian tumour growth. Cancer Immunology, Immunotherapy, 73 (5) 80, 1-12. doi: 10.1007/s00262-024-03674-w |
2023 Journal Article miR-146a inhibits ovarian tumour growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltrationChen, Rui, Coleborn, Elaina, Bhavsar, Chintan, Wang, Yue, Alim, Louisa, Wilkinson, Andrew N., Tran, Michelle A., Irgam, Gowri, Atluri, Sharat, Wong, Kiefer, Shim, Jae-Jun, Adityan, Siddharth, Lee, Ju-Seog, Overwijk, Willem W., Steptoe, Raymond, Yang, Da and Wu, Sherry Y. (2023). miR-146a inhibits ovarian tumour growth in vivo via targeting immunosuppressive neutrophils and enhancing CD8+ T cell infiltration. Molecular Therapy - Oncolytics, 31 100725, 1-15. doi: 10.1016/j.omto.2023.09.001 |
2022 Journal Article Molecular analysis of short- versus long-term survivors of high-grade serous ovarian carcinomaStur, Elaine, Bayraktar, Emine, Dal Molin, Graziela Zibetti, Wu, Sherry Y., Mangala, Lingegowda S., Yao, Hui, Wang, Ying, Ram, Prahlad T., Corvigno, Sara, Chen, Hu, Liang, Han, Tworoger, Shelley S., Levine, Douglas A., Lutgendorf, Susan K., Liu, Jinsong, Moore, Kathleen N., Baggerly, Keith A., Karlan, Beth Y. and Sood, Anil K. (2022). Molecular analysis of short- versus long-term survivors of high-grade serous ovarian carcinoma. Cancers, 14 (17) 4198, 4198. doi: 10.3390/cancers14174198 |
2021 Journal Article Gene body methylation of the lymphocyte-specific gene CARD11 results in its overexpression and regulates cancer mTOR signalingMcGuire, Michael H., Dasari, Santosh K., Yao, Hui, Wen, Yunfei, Mangala, Lingegowda S., Bayraktar, Emine, Ma, Wencai, Ivan, Cristina, Shoshan, Einav, Wu, Sherry Y., Jonasch, Eric, Bar-Eli, Menashe, Wang, Jing, Baggerly, Keith A. and Sood, Anil K. (2021). Gene body methylation of the lymphocyte-specific gene CARD11 results in its overexpression and regulates cancer mTOR signaling. Molecular Cancer Research, 19 (11), 1917-1928. doi: 10.1158/1541-7786.MCR-20-0753 |
2021 Journal Article CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistanceMa, Shaolin, Mangala, Lingegowda S., Hu, Wen, Bayaktar, Emine, Yokoi, Akira, Hu, Wei, Pradeep, Sunila, Lee, Sanghoon, Piehowski, Paul D., Villar-Prados, Alejandro, Wu, Sherry Y., McGuire, Michael H., Lara, Olivia D., Rodriguez-Aguayo, Cristian, LaFargue, Christopher J., Jennings, Nicholas B., Rodland, Karin D., Liu, Tao, Kundra, Vikas, Ram, Prahlad T., Ramakrishnan, Sundaram, Lopez-Berestein, Gabriel, Coleman, Robert L. and Sood, Anil K. (2021). CD63-mediated cloaking of VEGF in small extracellular vesicles contributes to anti-VEGF therapy resistance. Cell Reports, 36 (7). doi: 10.1016/j.celrep.2021.109549 |
2021 Journal Article Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotypeMa, Shaolin, McGuire, Michael H., Mangala, Lingegowda S., Lee, Sanghoon, Stur, Elaine, Hu, Wen, Bayraktar, Emine, Villar-Prados, Alejandro, Ivan, Cristina, Wu, Sherry Y., Yokoi, Akira, Dasari, Santosh K., Jennings, Nicholas B., Liu, Jinsong, Lopez-Berestein, Gabriel, Ram, Prahlad and Sood, Anil K. (2021). Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype. Cell Reports, 34 (6). doi: 10.1016/j.celrep.2021.108726 |
2020 Journal Article HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracilMori, Noriko, Mironchik, Yelena, Wildes, Flonné, Wu, Sherry Y., Mori, Kanami, Krishnamachary, Balaji and Bhujwalla, Zaver M. (2020). HIF and COX-2 expression in triple negative breast cancer cells with hypoxia and 5-fluorouracil. Current Cancer Reports, 2 (1), 54-63. doi: 10.25082/CCR.2020.01.005 |
2020 Journal Article Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translationAdityan, Siddharth, Tran, Michelle, Bhavsar, Chintan and Wu, Sherry Y. (2020). Nano-therapeutics for modulating the tumour microenvironment: design, development, and clinical translation. Journal of Controlled Release, 327 (Acta Biomater. 62 2017), 512-532. doi: 10.1016/j.jconrel.2020.08.016 |
2020 Journal Article The hidden role of paxillin: localization to nucleus promotes tumor angiogenesisNoh, Kyunghee, Duc-Hiep Bach, , Choi, Hyun-Jin, Kim, Mark S., Wu, Sherry Y., Pradeep, Sunila, Ivan, Cristina, Cho, Min-Soon, Bayraktar, Emine, Rodriguez-Aguayo, Cristian, Dasari, Santosh K., Stur, Elaine, Mangala, Lingegowda S., Lopez-Berestein, Gabriel and Sood, Anil K. (2020). The hidden role of paxillin: localization to nucleus promotes tumor angiogenesis. Oncogene, 40 (2), 384-395. doi: 10.1038/s41388-020-01517-3 |
2020 Journal Article Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesiclesLiu, Yuan, Wu, Sherry, Koo, Yeonjong, Yang, An, Dai, Yanwan, Khant, Htet, Osman, Samantha R., Chowdhury, Mamur, Wei, Haichao, Li, Yang, Court, Karem, Hwang, Elaine, Wen, Yunfei, Dasari, Santosh K., Nguyen, Michael, Tang, E. Chia-Cheng, Chehab, E. Wassim, de Val, Natalia, Braam, Janet and Sood, Anil K. (2020). Characterization of and isolation methods for plant leaf nanovesicles and small extracellular vesicles. Nanomedicine-Nanotechnology Biology and Medicine, 29 102271. doi: 10.1016/j.nano.2020.102271 |
2020 Journal Article NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitorsMiyake, Takahito M., Pradeep, Sunila, Bayraktar, Emine, Stur, Elaine, Handley, Katelyn F., Wu, Sherry Y., Rodriguez-Aguayo, Cristian, Lee, Ju-Seog, Lopez-Berestein, Gabriel, Coleman, Robert L. and Sood, Anil K. (2020). NRG1/ERBB3 pathway activation induces acquired resistance to XPO1 inhibitors. Molecular Cancer Therapeutics, 19 (8), 1727-1735. doi: 10.1158/1535-7163.MCT-19-0977 |
2019 Journal Article Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retentionShi, Sixiang, Li, Tingting, Wen, Xiaofei, Wu, Sherry Y., Xiong, Chiyi, Zhao, Jun, Lincha, Victor R., Chow, Diana S., Liu, Yiyao, Sood, Anil K. and Li, Chun (2019). Copper-64 labeled PEGylated exosomes for in vivo positron emission tomography and enhanced tumor retention. Bioconjugate Chemistry, 30 (10), 2675-2683. doi: 10.1021/acs.bioconjchem.9b00587 |
2019 Journal Article Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcomaEndo-Munoz, Liliana, Bennett, Tristram C., Topkas, Eleni, Wu, Sherry Y., Thamm, Douglas H., Brockley, Laura, Cooper, Maureen, Sommerville, Scott, Thomson, Maurine, O'Connell, Kathleen, Lane, Amy, Bird, Guy, Peaston, Anne, Matigian, Nicholas, Straw, Rodney C. and Saunders, Nicholas A. (2019). Auranofin improves overall survival when combined with standard of care in a pilot study involving dogs with osteosarcoma. Veterinary and Comparative Oncology, 18 (2) vco.12533, 206-213. doi: 10.1111/vco.12533 |
2019 Journal Article Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cellsMcGuire, Michael H., Herbrich, Shelley M., Dasari, Santosh K., Wu, Sherry Y., Wang, Ying, Rupaimoole, Rajesha, Lopez-Berestein, Gabriel, Baggerly, Keith A. and Sood, Anil K. (2019). Pan-cancer genomic analysis links 3'UTR DNA methylation with increased gene expression in T cells. Ebiomedicine, 43, 127-137. doi: 10.1016/j.ebiom.2019.04.045 |
2019 Journal Article Predicting novel therapies and targets: regulation of notch3 by the Bromodomain protein BRD4Villar-Prados, Alejandro, Wu, Sherry Y., Court, Karem A., Ma, Shaolin, LaFargue, Christopher, Chowdhury, Mamur A., Engelhardt, Margaret I., Ivan, Cristina, Ram, Prahlad T., Wang, Ying, Baggerly, Keith, Rodriguez-Aguayo, Cristian, Lopez-Berestein, Gabriel, Ming-Yang, Shyh, Maloney, David J., Yoshioka, Makoto, Strovel, Jeffrey W., Roszik, Jason and Sood, Anil K. (2019). Predicting novel therapies and targets: regulation of notch3 by the Bromodomain protein BRD4. Molecular Cancer Therapeutics, 18 (2), 421-436. doi: 10.1158/1535-7163.MCT-18-0365 |
2018 Journal Article Advances and challenges in nanomedicineHua, Susan and Wu, Sherry Y. (2018). Advances and challenges in nanomedicine. Frontiers in Pharmacology, 9 (Nov) 1397, 1397. doi: 10.3389/fphar.2018.01397 |
2018 Journal Article The advances and challenges in utilizing exosomes for delivering cancer therapeuticsYang, Mengliu and Wu, Sherry Y. (2018). The advances and challenges in utilizing exosomes for delivering cancer therapeutics. Frontiers in Pharmacology, 9 (JUL) 735, 735. doi: 10.3389/fphar.2018.00735 |
2017 Journal Article Immune cell profiling in cancer: molecular approaches to cell-specific identificationLyons, Yasmin A., Wu, Sherry Y., Overwijk, Willem W., Baggerly, Keith A. and Sood, Anil K. (2017). Immune cell profiling in cancer: molecular approaches to cell-specific identification. Npj Precision Oncology, 1 (26) 26. doi: 10.1038/s41698-017-0031-0 |
2017 Journal Article PRKCI promotes immune suppression in ovarian cancerSarkar, Sharmistha, Bristow, Christopher A., Dey, Prasenjit, Rai, Kunal, Perets, Ruth, Ramirez-Cardenas, Alejandra, Malasi, Shruti, Huang-Hobbs, Emmet, Haemmerle, Monika, Wu, Sherry Y., McGuire, Michael, Protopopov, Alexei, Jiang, Shan, Liu, Joyce F., Hirsch, Michelle S., Chang, Qing, Lazar, Alexander J., Sood, Anil K., Drapkin, Ronny, DePinho, Ronald, Draetta, Giulio and Chin, Lynda (2017). PRKCI promotes immune suppression in ovarian cancer. Genes and Development, 31 (11), 1109-1121. doi: 10.1101/gad.296640.117 |